The Amirov brothers, newly appointed owners of a controlling stake in the Shufersal retail chain, initially planned to appoint Professor Yitzhak Shapira as chairman of the board of directors with a part-time salary. However, this move was met with negative reactions in economic circles and prompted the Ministry of Health to intervene before the Securities Market Supervision Authority could voice its opinion.
The initial plan was for Professor Shapira to serve as a ceremonial chairman while retaining his position as deputy general director of Ichilov hospital. However, this plan was prevented by securities market management and later blocked by the Ministry of Health due to concerns about conflicts of interest.
The decision prompted controversy and highlighted the importance of transparency and avoiding conflicts of interest in corporate governance. The situation also serves as a reminder that corporate leaders must be mindful of their actions and ensure that they do not compromise their integrity or harm others.